Wegovy
Novo Nordisk · Prescription Weight Management
Wegovy® (Semaglutide)
One of the UK’s leading GLP-1 weight loss treatment — now available as a once-weekly injection or a once-daily tablet
Wegovy contains semaglutide, a GLP-1 receptor agonist that reduces hunger and helps you feel fuller for longer — with clinically proven weight loss of around 15% on the standard 2.4mg injection, and higher again on the new 7.2mg dose, alongside diet and exercise. The once-weekly injection is available now in six pen strengths from 0.25mg to 7.2mg, and the new once-daily tablet (MHRA-approved 11 June 2026) arrives from 7th July 2026.
Two Ways To Take Wegovy
Choose Your Wegovy Treatment
Both forms contain the same active ingredient, semaglutide, and produce comparable weight loss. Your pharmacist can help you decide which suits your lifestyle.
Prices include your online consultation and private prescription. Wegovy is a prescription-only medicine — a pharmacist-reviewed consultation is required before supply.
Proven Results
Is Wegovy Right For You?
Wegovy Injection vs Wegovy Tablet
Both forms of Wegovy contain semaglutide and produce comparable weight loss. The right choice comes down to your routine and preferences — here’s how they compare:
| Feature | Wegovy Injection | Wegovy Tablet |
|---|---|---|
| How it’s taken | Once-weekly pre-filled FlexTouch® pen | Once-daily tablet, swallowed whole |
| Food restrictions | None — take any time of day | Empty stomach + 30-minute fasting window |
| Strengths | 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg → 7.2mg | 1.5mg → 4mg → 9mg → 25mg |
| Weight loss (trial data) | Avg. ~15% (68 wks, STEP 1; see SmPC) | Up to 16.6% with full adherence; 13.6% overall (64 wks, OASIS 4) |
| Needles required? | Yes | No |
| Refrigeration? | Yes (2–8°C before first use) | No |
| Starting price | From £98.50/month | From £99.00/month |
| Available now? | Yes — available now | From 7th July 2026 |
Weight loss figures are from published clinical trials and represent averages or peak responder data. Individual results vary. All prices include consultation and prescription.
Want the full breakdown? Read our complete injection vs tablet guide, or if you’re already on the injection and thinking about switching, our pharmacists can guide you through the switching protocol.
The Wegovy Dose Journey — Injection & Tablet
Whichever form you choose, treatment starts at a low dose and steps up gradually — typically every 4 weeks — to give your body time to adjust and keep side effects manageable. Your prescriber may hold any step for longer if needed. Here’s how the two schedules run side by side:
| Stage | Injection (once weekly) | Tablet (once daily) |
|---|---|---|
| Step 1 | 0.25mg · starting dose | 1.5mg · starting dose |
| Step 2 | 0.5mg · escalating | 4mg · escalating |
| Step 3 | 1mg · escalating | 9mg · escalating |
| Step 4 | 1.7mg · escalating | 25mg · maintenance dose reached |
| Maintenance | 2.4mg · standard maintenance dose | 25mg · continues |
| Higher dose option Where clinically appropriate |
7.2mg · prescriber-guided escalation from 2.4mg | Not applicable — 25mg is the highest tablet strength |
Each “step” is typically 4 weeks, and the two treatments do not progress in lockstep — the injection escalates over 16 weeks before reaching its 2.4mg maintenance dose, while the tablet reaches its 25mg maintenance dose over a shorter escalation of around 12 weeks. Your prescriber may hold any step for longer, or adjust the pace, to suit you.
Simple Process
How Ordering Wegovy Works
Complete Your Consultation
Fill in a short online health questionnaire — it only takes a few minutes and can be done at a time that suits you.
Pharmacist Review
One of our qualified pharmacists reviews your questionnaire and medical history to confirm Wegovy is safe and appropriate for you. We’ll be in touch if we need anything further.
Delivery or Collection
Injections arrive in temperature-controlled packaging on a delivery day you choose — or collect from a local Weldricks branch. Free tracked delivery, discreet plain packaging.
Am I Eligible?
Wegovy Eligibility
The same eligibility criteria apply to both the injection and the tablet. All patients must complete an online consultation reviewed by a Weldricks pharmacist before treatment can be approved.
You may be eligible if you…
- Have a BMI of 30 or above
- Have a BMI of 27 or above with a weight-related health condition (e.g. type 2 diabetes, high blood pressure, high cholesterol, sleep apnoea)
- Are aged 18 or over
- Are committed to lifestyle changes alongside treatment (diet and exercise)
- Are not pregnant or breastfeeding
You should not take Wegovy if you…
- Are allergic to semaglutide or any ingredient in Wegovy
- Have a personal or family history of medullary thyroid carcinoma (MTC)
- Have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- Are pregnant, planning to become pregnant, or breastfeeding
- Have had a serious allergic reaction to semaglutide previously
This is not a complete list. Our pharmacists will review your full medical history during your consultation. Please tell us about all medicines you take, including over-the-counter treatments and supplements.
Wegovy Side Effects
Like all medicines, Wegovy can cause side effects. They are most common when you first start treatment or after a dose increase, and usually improve as your body adjusts. Common side effects (may affect more than 1 in 10 people) include:
Content on this page has been written with reference to published clinical trial data (STEP 1 and OASIS 4, Novo Nordisk), the Wegovy Summary of Product Characteristics (eMC) and MHRA product information. Wegovy® is a registered trademark of Novo Nordisk A/S. Weldricks Pharmacy is registered with the General Pharmaceutical Council (GPhC No. 1091175). Side effects can be reported via the MHRA Yellow Card scheme.